The global comprehensive metabolic panel (CMP) testing market is growing due to rise in geriatric population and increase in incidence of lifestyle-associated ailments. CMP testing is advised either as a part of routine check-up or in case of metabolic disorders. At times, general symptoms such as fatigue also drive the physicians to recommend CMP testing.
The companies operating in comprehensive metabolic panel (CMP) testing market are working toward deployment of CMP testing kits to the under-developed and developing economies with the objective of widening the end-consumer base and bridging the gap between the availability of CMP testing kits in the developed and the ones mentioned above.
Comprehensive Metabolic Panel (CMP) testing measures the efficiency with which the kidney and liver are functioning. These organs determine the metabolism of the body.
This test helps in measuring the acid-base balance and electrolyte content, blood proteins, and blood sugar. Electrolytes are the mineral salts involved in several cellular processes, which include maintenance of body’s pH and fluid levels.
If one is availing medications for high blood pressure, CMP test helps in checking their effect on liver or kidneys.
Rising cases of diabetes and end-stage renal disease (ESRD) are compelling the patients to opt for CMP testing on regular basis.
| Attribute | Detail |
|---|---|
| Comprehensive Metabolic Panel (CMP) Testing Market Drivers |
|
Increase in occurrence of lifestyle-associated diseases due to uncontrolled smoking, unhealthy eating habits, and lack of physical activity is responsible for accelerating the demand for CMP testing.
Lifestyle-associated diseases cause chronic diseases, especially heart diseases, diabetes, stroke, metabolic syndrome, obesity, certain types of cancer, and chronic obstructive pulmonary disease.
As per the United Nations, by 2030, 70% of the global fatalities would be attributed to chronic diseases.
CMP testing at regular intervals helps in early detection of chronic ailments followed by treatment.
Need to quell the further spread of chronic ailments is thus catalyzing the comprehensive metabolic panel (CMP) testing market development.
It takes more calories to build as well as maintain muscles as compared to fat. It has been observed that individuals with a higher muscle mass generally have quicker metabolism that end up burning more calories. Moreover, one tends to lose muscles on getting older, which, in turn, slows down the metabolism.
Comprehensive Metabolic panel (CMP) testing facilitates measurement of 14 diverse substances in the blood sample. It provides vital information regarding metabolism and balance of some chemicals in the body.
In other words, CMP helps in checking the kidney and liver health, blood glucose, levels of protein, electrolyte and fluid balance (that can affect acid-base balance in the blood), and metabolism.
CMP testing can help the geriatric population in taking precautionary measures regarding metabolism and the other parameters mentioned above. As per the WHO, there were 1 billion individuals aged 60 and above in 2020 and the number is expected to increase to 1.4 billion by the year 2030.
Need to resort to preventive measures with immediate effect on the account of geriatric population’s risk to metabolic disorders is thus expanding the comprehensive metabolic panel (CMP) testing market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest comprehensive metabolic panel (CMP) testing industry analysis, North America dominated the comprehensive metabolic assay landscape in 2023 and the scenario is expected to remain the same during the forecast period. This is attributed to increase in incidence of chronic kidney disease (CKD) in the U.S. As per the CDC, over 15% of the adults in the U.S. are battling CKD.
Moreover, diabetes is found broadening the patient pool regarding PoC CMP testing. High blood pressure and diabetes are amongst the major attributes to CKD in the adults.
Asia Pacific’s significant comprehensive metabolic panel (CMP) testing market share is ascribed to enhancements in healthcare infrastructure and increase in geriatric population. As per the Asian Development Bank, 25% of the population of Asia Pacific is expected to be aged 60 and above by the year 2050.
The comprehensive metabolic panel (CMP) testing market manufacturers are engaged in organic as well as inorganic modes of development to strengthen their position. For instance, in December 2021, Sonic Healthcare completed acquisition of Propath, which has been known for diagnosing patients from 45 states in the U.S. and various other countries.
Comprehensive Metabolic Panel (CMP) testing market report highlights Roche Diagnostics, Scion Lab Services, LLC, Baptist Health, Walk-in Lab, LLC, Testing.com, My Care Labs, ARUP Laboratories, Blueprint Genetics Oy, Applied InGENuity Diagnostics, and Quest Diagnostics.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 11.0 Bn |
| Market Forecast (Value) in 2034 | US$ 18.5 Bn |
| Growth Rate (CAGR) | 4.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 11.0 Bn in 2023
It is projected to grow at a CAGR of 4.8% from 2024 to 2034
Growing prevalence of lifestyle-associated diseases and rise in geriatric population
Diagnostic laboratories segment accounted for the largest share in 2023
North America was the dominant region in 2023
Roche Diagnostics, Scion Lab Services, LLC, Baptist Health, Walk-in Lab, LLC, Testing.com, My Care Labs, ARUP Laboratories, Blueprint Genetics Oy, Applied InGENuity Diagnostics, and Quest Diagnostics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Comprehensive Metabolic Panel (CMP) Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2020-2034
6.3.1. Glucose
6.3.2. Calcium
6.3.3. Electrolytes
6.3.4. Kidney Function Tests
6.3.5. Liver Function Tests
6.3.6. Others (Protein, etc.)
6.4. Market Attractiveness Analysis, by Test Type
7. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2020-2034
7.3.1. Kidney Diseases
7.3.2. Liver Diseases
7.3.3. Diabetes
7.3.4. Others (Hypertension, etc.)
7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Diagnostic Laboratories
8.3.3. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Test Type, 2020-2034
10.3.1. Glucose
10.3.2. Calcium
10.3.3. Electrolytes
10.3.4. Kidney Function Tests
10.3.5. Liver Function Tests
10.3.6. Others (Protein, etc.)
10.4. Market Value Forecast, by Disease Indication, 2020-2034
10.4.1. Kidney Diseases
10.4.2. Liver Diseases
10.4.3. Diabetes
10.4.4. Others (Hypertension, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Diagnostic Laboratories
10.5.3. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Test Type
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Test Type, 2020-2034
11.3.1. Glucose
11.3.2. Calcium
11.3.3. Electrolytes
11.3.4. Kidney Function Tests
11.3.5. Liver Function Tests
11.3.6. Others (Protein, etc.)
11.4. Market Value Forecast, by Disease Indication, 2020-2034
11.4.1. Kidney Diseases
11.4.2. Liver Diseases
11.4.3. Diabetes
11.4.4. Others (Hypertension, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Diagnostic Laboratories
11.5.3. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Test Type, 2020-2034
12.3.1. Glucose
12.3.2. Calcium
12.3.3. Electrolytes
12.3.4. Kidney Function Tests
12.3.5. Liver Function Tests
12.3.6. Others (Protein, etc.)
12.4. Market Value Forecast, by Disease Indication, 2020-2034
12.4.1. Kidney Diseases
12.4.2. Liver Diseases
12.4.3. Diabetes
12.4.4. Others (Hypertension, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Diagnostic Laboratories
12.5.3. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Test Type, 2020-2034
13.3.1. Glucose
13.3.2. Calcium
13.3.3. Electrolytes
13.3.4. Kidney Function Tests
13.3.5. Liver Function Tests
13.3.6. Others (Protein, etc.)
13.4. Market Value Forecast, by Disease Indication, 2020-2034
13.4.1. Kidney Diseases
13.4.2. Liver Diseases
13.4.3. Diabetes
13.4.4. Others (Hypertension, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Diagnostic Laboratories
13.5.3. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Test Type, 2020-2034
14.3.1. Glucose
14.3.2. Calcium
14.3.3. Electrolytes
14.3.4. Kidney Function Tests
14.3.5. Liver Function Tests
14.3.6. Others (Protein, etc.)
14.4. Market Value Forecast, by Disease Indication, 2020-2034
14.4.1. Kidney Diseases
14.4.2. Liver Diseases
14.4.3. Diabetes
14.4.4. Others (Hypertension, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Diagnostic Laboratories
14.5.3. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Roche Diagnostics
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Scion Lab Services, LLC
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Baptist Health
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Walk-in Lab, LLC
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Testing.com
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. My Care Labs
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. ARUP Laboratories
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Blueprint Genetics Oy
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Applied InGENuity Diagnostics
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Quest Diagnostics
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 02: Global Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 03: Global Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 07: North America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 08: North America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 11: Europe Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 12: Europe Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 15: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 16: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 19: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 20: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Test Type, 2020-2034
Table 23: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 24: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue (US$ Bn), by Test Type, 2023
Figure 03: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share, by Test Type, 2023
Figure 04: Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue (US$ Bn), by Disease Indication, 2023
Figure 05: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share, by Disease Indication, 2023
Figure 06: Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share, by End-user, 2023
Figure 08: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share, by Region, 2023
Figure 09: Global Comprehensive Metabolic Panel (CMP) Testing Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 11: Global Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 13: Global Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 14: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Comprehensive Metabolic Panel (CMP) Testing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 22: North America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 23: North America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 26: North America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Comprehensive Metabolic Panel (CMP) Testing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 31: Europe Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 32: Europe Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 35: Europe Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 40: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 41: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 44: Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 49: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 50: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 53: Latin America Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 58: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 59: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 62: Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Comprehensive Metabolic Panel (CMP) Testing Market
